Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 66 Leukemia 63 Leukemia, Lymphocytic, Chronic, B-Cell 59 Myelodysplastic Syndromes 49 Lymphoma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, Non-Hodgkin 41 Multiple Myeloma 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35 Hodgkin Disease 33 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 16 Recurrence 15 Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Follicular 14 Primary Myelofibrosis 13 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

blinatumomab 4 Rituximab 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibritumomab tiuxetan 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡